Compare Immunovant Inc. Common Stock (IMVT) vs Veeva Systems (VEEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Veeva Systems — how do they compare? Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B), while Veeva Systems trades at $287.4 (market cap $46.12B). The key difference: Veeva Systems is far larger — about 7.4× Immunovant Inc. Common Stock's market cap, and Veeva Systems is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| IMVT | VEEV | |
|---|---|---|
Market Cap | $6.25B | $46.12B |
Volume | 1,755,411 | 921,537 |
Sector | Health | Technology |
52-Week High | $44.96 | $299.10 |
52-Week Low | $17.03 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $5.35B | $39.03B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Veeva Systems
Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →
